C1QTNF9 and chronic kidney disease: Therefore, in this study, we measured the plasma levels of CTRP9 in subjects with T2D representing a wide range of renal function and investigated the clinical association of plasma CTRP9 level with the intima-media thickness (IMT) of the carotid artery separately in subjects with CKD and in those without CKD.